To test the expression of FBLN1 in lung cancers we first evaluated the TCGA lung cancer dataset (Campbell et al., 2016) and detected ∼ 2.41 fold decrease in FBLN1 transcript levels in lung cancer samples relative to normal lung (Figure 1A). The gene discussed is FBLN1; the disease is lung cancer.